STAT1 pathway mediates amplification of metastatic potential and resistance to therapy - Wikidata - awgldk - TriplyDB

STAT1 pathway mediates amplification of metastatic potential and resistance to therapy

STAT1 pathway mediates amplification of metastatic potential and resistance to therapy

http://www.wikidata.org/entity/Q33463332

about

Biomarkers of residual disease, disseminated tumor cells, and metastases in the MMTV-PyMT breast cancer model IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage Interferons as inducers of apoptosis in malignant cells Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity Peripheral immune cell gene expression changes in advanced non-small cell lung cancer patients treated with first line combination chemotherapy Expression signature of IFN/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype-specific manner High STAT1 mRNA levels but not its tyrosine phosphorylation are associated with macrophage infiltration and bad prognosis in breast cancer.DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells Interferons and their stimulated genes in the tumor microenvironment Exploring molecular links between lymph node invasion and cancer prognosis in human breast cancer.Zoledronic acid sensitizes renal cell carcinoma cells to radiation by downregulating STAT1 Non-invasive, simultaneous quantification of vascular oxygenation and glucose uptake in tissue.Progression of cancer from indolent to aggressive despite antigen retention and increased expression of interferon-gamma inducible genes Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale In Silico cancer cell versus stroma cellularity index computed from species-specific human and mouse transcriptome of xenograft models: towards accurate stroma targeting therapy assessment.Tripartite motif 24 (Trim24/Tif1α) tumor suppressor protein is a novel negative regulator of interferon (IFN)/signal transducers and activators of transcription (STAT) signaling pathway acting through retinoic acid receptor α (Rarα) inhibition Stat1 stimulates cap-independent mRNA translation to inhibit cell proliferation and promote survival in response to antitumor drugs Imaging of tumor clones with differential liver colonization Does Radiotherapy Have Curative Potential in Metastatic Patients? The Concept of Local Therapy in Oligometastatic Breast Cancer.A signature of immune function genes associated with recurrence-free survival in breast cancer patients.Unphosphorylated STAT1 promotes sarcoma development through repressing expression of Fas and bad and conferring apoptotic resistance.Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner.CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors.The tumor suppressor function of STAT1 in breast cancer Periostin cooperates with mutant p53 to mediate invasion through the induction of STAT1 signaling in the esophageal tumor microenvironment.Crosstalk between PKCα and Notch-4 in endocrine-resistant breast cancer cells.RIG-I-like receptor LGP2 protects tumor cells from ionizing radiation.The functions of signal transducers and activators of transcriptions 1 and 3 as cytokine-inducible proteins.Phosphorylation meets nuclear import: a review.Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs.Portrait of inflammatory response to ionizing radiation treatment.Comparative gene-expression profiling of CD133(+) and CD133(-) D10 melanoma cells.Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome.Exploiting Gene Expression Kinetics in Conventional Radiotherapy, Hyperfractionation, and Hypofractionation for Targeted Therapy.Radiotherapy and immunotherapy: a beneficial liaison?Hypoxia modulates A431 cellular pathways association to tumor radioresistance and enhanced migration revealed by comprehensive proteomic and functional studies.Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastoma.

P2860

Q21090788-73B2FCC1-DBA6-4491-BD64-46285333AE79 Q24337202-1382AFF8-5747-41D1-9716-50008F28C271 Q27010207-6E43FB8A-689A-4106-B245-971CA972E929 Q27304386-D9485495-1AE4-4A8B-A77A-169A507787F0 Q28304923-7E7DE332-AC23-4012-8C37-36EE24997460 Q28394867-97BF0068-8E22-454D-8D5A-42BAF401A990 Q28740313-9BCFA400-FFD5-4211-BDCF-4802387E74EB Q33611598-C3B8B1B8-D912-4A10-83C2-70764062996C Q33805578-28935768-31B0-4D0C-AB02-753D4E5DD533 Q33988567-FF6B8A24-68F7-4113-8D15-F54DB6178ABD Q34333453-34579D3B-606B-4168-BD32-53B63FCE7839 Q34760588-C849A2CD-CEA3-4701-BB52-93F9AF13FBF3 Q35031920-0CAF9577-E96E-499B-9C66-5955C00AFA07 Q35079913-BE81A1B8-4AC4-4ED4-8A64-0BA7CC82D5C5 Q35107727-2646DE10-6762-4491-A8A6-55A9F0876D7A Q35144499-83363416-E61B-4B20-A11E-D3D8D6CE094D Q35216502-BC5A5D9B-758F-44E7-AE56-966053F9B8DE Q35312100-34C34271-31C3-4400-916C-CB917070B1A5 Q35567160-FD483670-F968-4960-86A7-175F38710F40 Q35765080-FAA5CE00-79BA-4FF0-B394-1483C22C6C88 Q35976055-888B444C-A93C-4EE8-9EFB-D02561421642 Q36199789-F2DEF93A-F327-4CF4-B396-2CEC98D66A7C Q36588875-5F35EBEA-5D9D-446E-9A75-81EE79F4249A Q36599823-58ED730F-D491-4D0E-B273-8D7672E9C4F9 Q36634569-9CA5FA7F-8C0B-497B-8F5D-F7988997163C Q36940404-5CC4089D-8D0C-4339-B776-D50FA6DA300A Q37008995-11930E1E-020F-4E35-80CF-4AE472685B00 Q37137255-0EF3AAD7-1E32-480B-B45C-0D03B356613F Q37137262-DB5A8FCB-7E4E-4F33-A230-F89C30E590D2 Q37543955-F774D9D3-9A38-4648-B616-95FE8278FADD Q37821935-D2D82DF0-F301-4196-AEF9-AED2071D0082 Q37823682-37557003-79C6-40D5-B0B8-50F2224317E5 Q38223512-1162BC2A-3ED9-4094-B219-CB5689AC9B0B Q38364169-8938F7B3-501E-4DC9-BDBB-F56A6A929E8A Q38842832-6E5355EA-1443-4B76-84A3-94316F4688AC Q38867618-EBCF1A53-F18C-4646-BB0C-80CDE9A10B98 Q38952268-68DEE76E-232F-4CE0-A57C-6FC256BC8BC7 Q39017268-16CC745E-523D-4FFB-BE16-CCA3A6ED76A2 Q39233873-D84551A7-0CA6-404E-8E55-6904ACB815EE Q40213573-8A112F2A-1FD9-46D1-A66B-EF2D9F3091EA

P2860

STAT1 pathway mediates amplification of metastatic potential and resistance to therapy

http://www.wikidata.org/entity/Q33463332

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

STAT1 pathway mediates amplification of metastatic potential and resistance to therapy

@ast

STAT1 pathway mediates amplification of metastatic potential and resistance to therapy

@en

type

label

STAT1 pathway mediates amplification of metastatic potential and resistance to therapy

@ast

STAT1 pathway mediates amplification of metastatic potential and resistance to therapy

@en

prefLabel

STAT1 pathway mediates amplification of metastatic potential and resistance to therapy

@ast

STAT1 pathway mediates amplification of metastatic potential and resistance to therapy

@en

P1433

Q33463332-C9681EF1-F6F7-4BA1-8508-F2B3FD9735D1

P1476

Q33463332-B06E8409-11D8-4662-BD7D-3164C2A77A23

P2093

Q33463332-10762CE3-A6FE-408C-833C-0AC3261E62E7

Q33463332-2C47EF22-FCB1-474A-860F-78F293F970F1

Q33463332-6C1A1EE6-CA7D-476F-8939-F20433AEFC57

Q33463332-9AED384F-A571-4D3C-AF30-49203AA520AF

Q33463332-CC05194C-872B-439F-9B84-68CBF8E5D948

Q33463332-E278B5BD-07D1-4BB9-AC2B-A5EB3C49E1BA

Q33463332-E6AAD331-32F2-4ECC-8C1E-59FBE28F847D

Q33463332-ED8211DA-C202-4729-A4B3-9280D6E643BF

Q33463332-F0746CD6-8AC5-48D7-A83E-56FADE01035B

Q33463332-F7B0DE81-8004-4892-BEDA-72B1C3A5560A

P2860

Q33463332-01EC80FA-4C7B-4DEB-BDA0-9EAA210FE400

Q33463332-0235DCB2-94F4-4A79-A573-3EA338F245CB

Q33463332-02F8AB9B-F284-4C15-AD44-2418CAE906F5

Q33463332-0B621574-1B29-42E7-8913-65337D2F2B43

Q33463332-0E000D44-3CA9-4E6E-AE36-0EEBDB1F662D

Q33463332-11D80720-3578-48A0-9BFB-BA5B8AB75112

Q33463332-146A73E8-A4A1-4FC4-9ECD-4A7047B152F3

Q33463332-1AD785AF-1629-4FFF-A886-7C04AF20F659

Q33463332-2408EDCF-2366-4296-86B2-A46832CDF4B8

Q33463332-28353EF5-7787-4A56-9D3B-76454725B530

P304

Q33463332-07F4C243-2B58-4692-BF82-49AF79C34BCB

P31

Q33463332-D1546BD2-824C-4420-8272-D0D91590D1F9

P356

Q33463332-B3538A45-048C-45B0-AB17-D912C6522FE3

P407

Q33463332-E093FAF2-6614-4356-B452-AB25B90B2CB6

P433

Q33463332-577C3F7D-7265-4930-ACFA-CF9D131897E8

P478

Q33463332-01DC3919-5981-4F92-991E-ED2213305E3D

P50

Q33463332-70D83877-DE74-4808-985B-6066329425E6

Q33463332-7A558676-B87A-4C88-B080-5B4CED607D2B

Q33463332-D1F060FC-9465-4844-9F91-26BC7523F95E

Q33463332-E881415D-E4DC-406C-AE96-3FFF5479207D

P577

Q33463332-E1153BE0-5343-40F7-87AB-87BF659A768D

P5875

Q33463332-D4F4842E-D8E9-49AF-8A64-0CEE9A264372

P698

Q33463332-72A241BD-5395-4234-B9AB-B66063EF9787

P932

Q33463332-AA340A30-A9E0-4307-8A5A-47F1D37AD4AA

P356

JOURNAL.PONE.0005821

P1433

P1476

STAT1 pathway mediates amplification of metastatic potential and resistance to therapy

@en

P2093

Harold G Sutton

http://www.w3.org/2001/XMLSchema#string

Mara G Beveridge

http://www.w3.org/2001/XMLSchema#string

Michael A Beckett

http://www.w3.org/2001/XMLSchema#string

Michael Y Shao

http://www.w3.org/2001/XMLSchema#string

Mihir Bhayani

http://www.w3.org/2001/XMLSchema#string

Mitchell C Posner

http://www.w3.org/2001/XMLSchema#string

Nikolai N Khodarev

http://www.w3.org/2001/XMLSchema#string

Paul Roach

http://www.w3.org/2001/XMLSchema#string

Ravi F Sood

http://www.w3.org/2001/XMLSchema#string

Sean P Pitroda

http://www.w3.org/2001/XMLSchema#string

P2860

Antiviral actions of interferons

Seeding and propagation of untransformed mouse mammary cells in the lung

Protein ISGylation modulates the JAK-STAT signaling pathway

Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers

Transcriptional Activation of Interferon-Stimulated Genes but Not of Cytokine Genes after Primary Infection of Rhesus Macaques with Dengue Virus Type 1

Molecular portraits of human breast tumours

The roles of IFN gamma in protection against tumor development and cancer immunoediting

Cancer immunoediting: from immunosurveillance to tumor escape

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein

P304

e5821

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0005821

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Ralph Weichselbaum

Helena J Mauceri

P577

2009-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26273678

http://www.w3.org/2001/XMLSchema#string

P698

19503789

http://www.w3.org/2001/XMLSchema#string

P932

2688034

http://www.w3.org/2001/XMLSchema#string